Pharma’s most expensive question is the last one asked
Whether a drug can secure reimbursement is pharma's billion-dollar question, and the companies that succeed will be those that answer it sooner.
Newsletters and Deep Dive digital magazine
Whether a drug can secure reimbursement is pharma's billion-dollar question, and the companies that succeed will be those that answer it sooner.
The future of drug development is not scientists versus algorithms. It is scientists and algorithms working together.
Digital Opinion Leaders with regional followings are shaping prescribing behaviour in ways that international Key Opinion Leaders are not.
We need to step away from the passive, broad concept of omnichannel and adopt a far more active, disciplined framework: omnideployment.
With AI, trial sponsors are now reducing risk, accelerating timelines, and driving innovation by modelling what is most likely to work in the future.
Editor's Picks
Newsletters and Deep Dive
digital magazine